A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context

Abstract

Objective: This review describes the current scenario of a priority group of emerging infectious diseases (EIDs) listed by World Health Organization (WHO), and their main determinants and drivers for the emergence/spread of the diseases. The gaps and strategies developed by India to meet the WHO guidelines on the effective control of epidemic-prone diseases and outbreaks are also presented in the review. Methods: Epidemiologic information of EIDs, namely Crimean-Congo hemorrhagic fever (CCHF), Ebola and Marburg viruses (EboV and MarV), Zika virus (ZIKAV), Rift Valley fever (RVF), Middle East respiratory syndrome, severe acute respiratory syndrome (SARS), Nipah and Hendra virus (NiV and HeV), and Lassa fever virus (LASV), was drawn from international and national electronic databases to assess the situation. A brief view on the novel coronavirus disease 2019 (COVID-19) in India is also included. Results: There are no reports for human infection of EboV, MarV, RVF, and LASV in India. CCHF, SARS, ZIKAV, and NiV have been involved in outbreaks in eight states of India, while COVID-19 is currently reported from majority of states. India has deeply strengthened its surveillance and response system of outbreaks and epidemic-prone diseases. Conclusions: Despite its enormous improvements made in the anticipation of such threats, still more efforts are needed in sensitization of populations as well as hospital management in the context to EIDs, as addressed in the review. Furthermore, there is still a need for more research and development activities to efficiently control EIDs.

Plasmodium cynomolgi in humans: current knowledge and future directions of an emerging zoonotic malaria parasite

“…This relationship between monkeys, mosquitoes, and human is crucial for emergence of and spread of Pcy parasites in humans. The expansion of humans and anthropogenic activities such as deforestation, forestry activities, and climate change are probably the leading drivers, thereby increasing chances for simian parasites to enlarge their host spectrum through emergence to local human populations from these countries, as seen for P. knowlesi and other emerging pathogens [ 88 – 91 ]. Such possibility for invading humans is also driven by the presence of competent and anthropophilic mosquito vectors.…”

Serum biomarkers for nutritional status as predictors in COVID-19 patients before and after vaccination

“…The second epidemiological transition occurred in the 1970s when man seemed to have controlled infectious diseases and focused on the fight against cancer, cardiovascular or neurodegenerative diseases and obesity among other conditions ( Chambaere et al, 2017 ). However, with the globalization of trade, international relations, and destruction of ecosystems, the third epidemiological transition occurred, marked by the appearance of re-emerging and emerging diseases such as human immunodeficiency virus (HIV) infections, Lyme disease, dengue fever, Zika virus, Crimean-Congo hemorrhagic fever (CCHF), epidemic neuropathy, middle East respiratory syndrome (MERS), severe acute respiratory syndrome (SARS) and coronavirus disease 2019 (COVID-19) that are reversing, in some measure, the effects of the second epidemiological transition ( Ndow et al, 2019 , Geisbert and Jahrling, 2004 , Watkins, 2018 , Kojom and Singh, 2021 , de la Fuente and Rodríguez, 1999 ). Multiple factors affect epidemiological transitions, including pathogen, social, political, and environmentally associated risks such as interspecies pathogen transmission and diet and its effect on metabolism, immunity and the composition of the intestinal and lung microbiota ( Ndow et al, 2019 , de la Fuente and Rodríguez, 1999 , de la Fuente, 1999 , Weiss and McMichael, 2004 , Webby et al, 2004 , Petersen et al, 2018 , Rohr et al, 2019 , Cassotta et al, 2020 , Wang et al, 2021 , Farsi et al, 2022 ).…”

Acute neurologic emerging flaviviruses

“…Multiple intersecting factors, including environmental changes, host immunological factors, and pathogen dynamics, are intimately connected to the emergence and re-emergence of communicable diseases. 1 – 3 There is a large and expanding list of communicable diseases that can cause neurological damage, either through direct or indirect routes. Novel pathogens of neurotropic potential have been identified through advanced diagnostic techniques, including metagenomic next-generation sequencing, but there are also known pathogens which have expanded their geographic distribution to infect non-immune individuals.…”